BRWA
CSBR icon

B. Riley Wealth Advisors’s Champions Oncology CSBR Stock Holding History

B. Riley Wealth Advisors’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,988
Closed -$21K – 549
2016
Q3 		$21K Hold
11,988
– – ﹤0.01% 608
2016
Q2 		$26K Buy
+11,988
New +$37.5K 0.01% 606

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

B. Riley Wealth Advisors's CSBR Position: Q4 2016 in Review

B. Riley Wealth Advisors sold out of Champions Oncology (CSBR) in Q4 2016, closing a stake of 11,988 shares — an estimated $21K sold.

B. Riley Wealth Advisors first reported a position in CSBR in Q2 2016 and held it in 2 quarters. The position peaked at $26K in Q2 2016. 11 funds tracked by Wall St. Rank hold CSBR as of Q4 2016.

  • B. Riley Wealth Advisors reported no remaining Champions Oncology position as of Q4 2016 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 11,988 Champions Oncology shares in Q4 2016, an estimated $21K.
  • B. Riley Wealth Advisors first reported a position in Champions Oncology in Q2 2016 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Champions Oncology position peaked at $26K in Q2 2016.
  • 11 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2016.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.